Logo image of RAY

RAYTECH HOLDING LTD (RAY) Stock Fundamental Analysis

NASDAQ:RAY - VGG7385S1011 - Common Stock

2.48 USD
-0.22 (-8.15%)
Last: 8/22/2025, 8:00:02 PM
2.5 USD
+0.02 (+0.81%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

6

RAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 19 industry peers in the Distributors industry. RAY gets an excellent profitability rating and is at the same time showing great financial health properties. RAY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year RAY was profitable.
RAY had a positive operating cash flow in the past year.
RAY had positive earnings in each of the past 5 years.
Each year in the past 5 years RAY had a positive operating cash flow.
RAY Yearly Net Income VS EBIT VS OCF VS FCFRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

RAY has a better Return On Assets (13.62%) than 94.74% of its industry peers.
RAY has a better Return On Equity (16.79%) than 73.68% of its industry peers.
The Return On Invested Capital of RAY (11.76%) is better than 78.95% of its industry peers.
RAY had an Average Return On Invested Capital over the past 3 years of 21.00%. This is in line with the industry average of 19.13%.
The 3 year average ROIC (21.00%) for RAY is well above the current ROIC(11.76%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROIC 11.76%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
RAY Yearly ROA, ROE, ROICRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

Looking at the Profit Margin, with a value of 10.59%, RAY belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
RAY's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.48%, RAY belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
In the last couple of years the Operating Margin of RAY has declined.
The Gross Margin of RAY (22.10%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of RAY has declined.
Industry RankSector Rank
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
RAY Yearly Profit, Operating, Gross MarginsRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RAY is creating value.
Compared to 1 year ago, RAY has more shares outstanding
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RAY Yearly Shares OutstandingRAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 5M 10M 15M
RAY Yearly Total Debt VS Total AssetsRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

RAY has an Altman-Z score of 31.53. This indicates that RAY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RAY (31.53) is better than 94.74% of its industry peers.
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 31.53
ROIC/WACC1.12
WACC10.49%
RAY Yearly LT Debt VS Equity VS FCFRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 20M 40M 60M

2.3 Liquidity

A Current Ratio of 5.29 indicates that RAY has no problem at all paying its short term obligations.
RAY's Current ratio of 5.29 is amongst the best of the industry. RAY outperforms 89.47% of its industry peers.
A Quick Ratio of 5.19 indicates that RAY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.19, RAY belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 5.19
RAY Yearly Current Assets VS Current LiabilitesRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

RAY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.16%.
Measured over the past years, RAY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.14% on average per year.
RAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.00%.
Measured over the past years, RAY shows a very strong growth in Revenue. The Revenue has been growing by 20.41% on average per year.
EPS 1Y (TTM)-25.16%
EPS 3Y-4.14%
EPS 5YN/A
EPS Q2Q%-23.49%
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAY Yearly Revenue VS EstimatesRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

RAY is valuated quite expensively with a Price/Earnings ratio of 27.56.
RAY's Price/Earnings ratio is in line with the industry average.
RAY is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.56
Fwd PE N/A
RAY Price Earnings VS Forward Price EarningsRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

RAY's Enterprise Value to EBITDA ratio is in line with the industry average.
RAY's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 135.89
EV/EBITDA 65.74
RAY Per share dataRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

RAY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RAY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAYTECH HOLDING LTD

NASDAQ:RAY (8/22/2025, 8:00:02 PM)

After market: 2.5 +0.02 (+0.81%)

2.48

-0.22 (-8.15%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.57%
Inst Owner ChangeN/A
Ins Owners31.19%
Ins Owner ChangeN/A
Market Cap108.13M
AnalystsN/A
Price TargetN/A
Short Float %6.64%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.56
Fwd PE N/A
P/S 6.93
P/FCF 135.89
P/OCF 135.89
P/B 10.98
P/tB 10.98
EV/EBITDA 65.74
EPS(TTM)0.09
EY3.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY0.74%
OCF(TTM)0.02
OCFY0.74%
SpS0.36
BVpS0.23
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROCE 15.03%
ROIC 11.76%
ROICexc N/A
ROICexgc N/A
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
FCFM 5.1%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.84%
ROCE(5y)49.77%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
F-Score4
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 53.78%
Profit Quality 48.14%
Current Ratio 5.29
Quick Ratio 5.19
Altman-Z 31.53
F-Score4
WACC10.49%
ROIC/WACC1.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)135.97%
Profit Quality(5y)122.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.16%
EPS 3Y-4.14%
EPS 5YN/A
EPS Q2Q%-23.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.86%
EBIT growth 3Y-10.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.5%
FCF growth 3Y-8.86%
FCF growth 5YN/A
OCF growth 1Y-60.5%
OCF growth 3Y-8.91%
OCF growth 5YN/A